A Study to Assess the Safety, Tolerability and Efficacy of RG2417 in Bipolar I Depression
- First Posted Date
- 2008-12-19
- Last Posted Date
- 2011-01-17
- Lead Sponsor
- Repligen Corporation
- Target Recruit Count
- 180
- Registration Number
- NCT00812058
- Locations
- ๐บ๐ธ
Duke University Medical Center, Durham, North Carolina, United States
๐บ๐ธUniversity of Cincinnati, Cincinnati, Ohio, United States
๐บ๐ธWestern Psychiatric Institute Clinic, Pittsburg, Pennsylvania, United States
Safety and Efficacy of Synthetic Human Secretin-Enhanced MRCP in Subjects With Abnormalities of the Pancreas
Phase 3
Completed
- Conditions
- Pancreatitis
- Interventions
- Drug: RG1068 (synthetic human secretin)
- First Posted Date
- 2008-04-17
- Last Posted Date
- 2009-12-03
- Lead Sponsor
- Repligen Corporation
- Target Recruit Count
- 258
- Registration Number
- NCT00660335
Phase II Study to Assess RG2417 in the Treatment of Bipolar I Depression
Phase 2
Completed
- Conditions
- Bipolar Depression
- First Posted Date
- 2006-05-08
- Last Posted Date
- 2007-11-09
- Lead Sponsor
- Repligen Corporation
- Target Recruit Count
- 80
- Registration Number
- NCT00322764
- Locations
- ๐บ๐ธ
University of Cincinnati, Cincinnati, Ohio, United States
๐บ๐ธMassachusetts General Hospital, Boston, Massachusetts, United States
๐บ๐ธCarman Research, Smyrna, Georgia, United States
RG2133 (2',3',5'-Tri-O-Acetyluridine) in Mitochondrial Disease
Phase 1
Terminated
- Conditions
- Mitochondrial Diseases
- First Posted Date
- 2003-05-08
- Last Posted Date
- 2005-08-05
- Lead Sponsor
- Repligen Corporation
- Target Recruit Count
- 12
- Registration Number
- NCT00060515
Synthetic Human Secretin in Children With Autism and Gastrointestinal Dysfunction
Phase 3
Terminated
- Conditions
- Autism
- First Posted Date
- 2002-05-09
- Last Posted Date
- 2005-11-21
- Lead Sponsor
- Repligen Corporation
- Registration Number
- NCT00036231
Synthetic Human Secretin in Children With Autism
Phase 3
Completed
- Conditions
- Autism
- First Posted Date
- 2002-05-09
- Last Posted Date
- 2005-08-05
- Lead Sponsor
- Repligen Corporation
- Registration Number
- NCT00036244
- Locations
- ๐บ๐ธ
Southwest Autism Research Center, Phoenix, Arizona, United States
๐บ๐ธChildren's Hospital and Research Center at Oakland, Oakland, California, United States
๐บ๐ธPuget Sound Neurology, Edmonds, Washington, United States
ยฉ Copyright 2025. All Rights Reserved by MedPath